Reconstitution of the Human Nigro-striatal Pathway on-a-Chip Reveals OPA1-Dependent Mitochondrial Defects and Loss of Dopaminergic Synapses.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
24 12 2019
Historique:
received: 19 03 2019
revised: 26 10 2019
accepted: 26 11 2019
entrez: 26 12 2019
pubmed: 26 12 2019
medline: 29 9 2020
Statut: ppublish

Résumé

Stem cell-derived neurons are generally obtained in mass cultures that lack both spatial organization and any meaningful connectivity. We implement a microfluidic system for long-term culture of human neurons with patterned projections and synaptic terminals. Co-culture of human midbrain dopaminergic and striatal medium spiny neurons on the microchip establishes an orchestrated nigro-striatal circuitry with functional dopaminergic synapses. We use this platform to dissect the mitochondrial dysfunctions associated with a genetic form of Parkinson's disease (PD) with OPA1 mutations. Remarkably, we find that axons of OPA1 mutant dopaminergic neurons exhibit a significant reduction of mitochondrial mass. This defect causes a significant loss of dopaminergic synapses, which worsens in long-term cultures. Therefore, PD-associated depletion of mitochondria at synapses might precede loss of neuronal connectivity and neurodegeneration. In vitro reconstitution of human circuitries by microfluidic technology offers a powerful system to study brain networks by establishing ordered neuronal compartments and correct synapse identity.

Identifiants

pubmed: 31875567
pii: S2211-1247(19)31634-1
doi: 10.1016/j.celrep.2019.11.111
pmc: PMC6941223
pii:
doi:

Substances chimiques

GTP Phosphohydrolases EC 3.6.1.-
OPA1 protein, human EC 3.6.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4646-4656.e4

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Références

Neuron. 2010 Apr 15;66(1):57-68
pubmed: 20399729
Annu Rev Pathol. 2019 Jan 24;14:449-468
pubmed: 30355153
Mov Disord. 2017 Mar;32(3):346-363
pubmed: 28251677
Cell Rep. 2018 Feb 20;22(8):2066-2079
pubmed: 29466734
Nat Med. 2018 Oct;24(10):1579-1589
pubmed: 30127392
Cell Stem Cell. 2014 Nov 6;15(5):653-65
pubmed: 25517469
Nat Protoc. 2006;1(4):2128-36
pubmed: 17487204
Ann Neurol. 2008 Jun;63(6):794-8
pubmed: 18496845
Cell Rep. 2016 Apr 26;15(4):692-699
pubmed: 27149846
J Neurosci. 2015 Jun 17;35(24):8979-85
pubmed: 26085623
Nat Methods. 2005 Aug;2(8):599-605
pubmed: 16094385
J Neurosci. 2016 Nov 16;36(46):11573-11584
pubmed: 27852766
Front Neurosci. 2017 Dec 13;11:671
pubmed: 29326542
Development. 2015 Sep 15;142(18):3178-87
pubmed: 26395144
Curr Opin Neurobiol. 2016 Feb;36:118-27
pubmed: 26705693
Cell Rep. 2012 Jun 28;1(6):703-14
pubmed: 22813745
Cell Rep. 2018 Jan 2;22(1):110-122
pubmed: 29298414
Mol Cell Neurosci. 2014 May;60:43-52
pubmed: 24662423
Cell Stem Cell. 2016 Nov 3;19(5):573-586
pubmed: 27814479
PLoS One. 2016 Jan 29;11(1):e0148219
pubmed: 26824698
Acta Neuropathol. 2016 Apr;131(4):539-48
pubmed: 26820848
Brain. 2013 Aug;136(Pt 8):2419-31
pubmed: 23884810
Neuron. 2018 May 16;98(4):865
pubmed: 29772206
Mov Disord. 2018 Apr;33(4):592-599
pubmed: 29436751
Nat Med. 2011 Dec;17(12):1570-6
pubmed: 22146428
Cell Stem Cell. 2013 Dec 5;13(6):635-6
pubmed: 24315433
Cell Stem Cell. 2009 Dec 4;5(6):584-95
pubmed: 19951687
Stem Cell Reports. 2019 Feb 12;12(2):230-244
pubmed: 30639210
Nat Rev Drug Discov. 2017 Feb;16(2):115-130
pubmed: 27980341
Nature. 2011 Nov 06;480(7378):547-51
pubmed: 22056989
ACS Chem Biol. 2013 Sep 20;8(9):1947-54
pubmed: 23859623
Brain. 2008 Feb;131(Pt 2):352-67
pubmed: 18222991
Science. 2018 Jun 29;360(6396):
pubmed: 29853555
Neurobiol Dis. 2017 Jul;103:101-112
pubmed: 28411117
Stem Cell Reports. 2015 Dec 8;5(6):933-945
pubmed: 26610635
Development. 2015 Apr 1;142(7):1375-86
pubmed: 25804741
J Neurosci. 2014 Oct 22;34(43):14304-17
pubmed: 25339743
Annu Rev Genet. 2018 Nov 23;52:271-293
pubmed: 30208291

Auteurs

Angelo Iannielli (A)

Stem Cell and Neurogenesis Unit, Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy; CNR Institute of Neuroscience, 20129 Milan, Italy.

Giovanni Stefano Ugolini (GS)

Department of Electronics, Information & Bioengineering, Politecnico di Milano, 20133 Milan, Italy.

Chiara Cordiglieri (C)

National Institute of Molecular Genetics "Romeo e Enrica Invernizzi" - INGM, 20122 Milan, Italy.

Simone Bido (S)

Stem Cell and Neurogenesis Unit, Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy.

Alicia Rubio (A)

Stem Cell and Neurogenesis Unit, Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy; CNR Institute of Neuroscience, 20129 Milan, Italy.

Gaia Colasante (G)

Stem Cell and Neurogenesis Unit, Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy.

Marco Valtorta (M)

Stem Cell and Neurogenesis Unit, Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy; CNR Institute of Neuroscience, 20129 Milan, Italy.

Tommaso Cabassi (T)

Stem Cell and Neurogenesis Unit, Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy.

Marco Rasponi (M)

Department of Electronics, Information & Bioengineering, Politecnico di Milano, 20133 Milan, Italy.

Vania Broccoli (V)

Stem Cell and Neurogenesis Unit, Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy; CNR Institute of Neuroscience, 20129 Milan, Italy. Electronic address: broccoli.vania@hsr.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH